Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

Simplified treatment regimens for HIV management may increase adherence. In this open-label, randomized, controlled trial, longer-acting (monthly) injectable cabotegravir plus rilpivirine was compared with standard oral treatment. At 48 weeks, similar viral suppression was seen with the two regimens...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2020-03, Vol.382 (12), p.1112-1123
Hauptverfasser: Swindells, Susan, Andrade-Villanueva, Jaime-Federico, Richmond, Gary J, Rizzardini, Giuliano, Baumgarten, Axel, Masiá, Mar, Latiff, Gulam, Pokrovsky, Vadim, Bredeek, Fritz, Smith, Graham, Cahn, Pedro, Kim, Yeon-Sook, Ford, Susan L, Talarico, Christine L, Patel, Parul, Chounta, Vasiliki, Crauwels, Herta, Parys, Wim, Vanveggel, Simon, Mrus, Joseph, Huang, Jenny, Harrington, Conn M, Hudson, Krischan J, Margolis, David A, Smith, Kimberly Y, Williams, Peter E, Spreen, William R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Simplified treatment regimens for HIV management may increase adherence. In this open-label, randomized, controlled trial, longer-acting (monthly) injectable cabotegravir plus rilpivirine was compared with standard oral treatment. At 48 weeks, similar viral suppression was seen with the two regimens.
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa1904398